In addition, in clinical conditions in patients with chronic pain such as rheumatoid arthritis, cancer pain, or neuropathic pain, the growth factor (NGF and IGF) levels are very high, which results in significant activation of nociceptors, thus enabling the maintenance of chronic neuropathic pain [46–48]. This evidence concerns the gene IGF1 and cancer.